Breast Cancer Research and Treatment

, Volume 109, Issue 1, pp 9–26

Progressive resistance training in breast cancer: a systematic review of clinical trials

  • Bobby Cheema
  • Catherine A. Gaul
  • Kirstin Lane
  • Maria A. Fiatarone Singh



Progressive resistance training (PRT) may be effective for targeting the sequelae of breast cancer and its treatment given the unique anabolic nature of this exercise modality. Therefore, our objectives were: (1) to systematically review studies that have prescribed PRT after breast cancer surgery, (2) to summarize the efficacy of PRT in this cohort, and (3) to delineate areas for future investigations.


A systematic review using computerized databases was performed.


The systematic review located 10 trials: Four uncontrolled trials, one controlled trial and five randomized controlled trials (RCTs). PRT was prescribed with aerobic training in 8/10 trials reviewed, and in isolation in 2/10 trials reviewed. Upper body PRT was prescribed in 7/10 trials, including 4/5 RCTs. No exacerbation of objectively measured or subjectively reported lymphedema symptoms was reported in any of these trials. Adverse events were rare, generally musculoskeletal in nature, and were managed effectively by conservative means. Overall, the studies we reviewed suggest that women surgically treated for breast cancer can derive health-related and clinical benefits by performing PRT after breast cancer surgery. Further research may be required to stimulate greater advocacy for PRT among oncologists, and in community care settings.


Robustly designed RCTs prescribing targeted PRT regimens throughout various phases of breast cancer treatment are warranted. RCTs with thorough, standardized reporting of interventions and adverse events are required to establish the efficacy of this intervention for the post-treatment management of breast cancer patients and survivors as a means to improve health status and quality of life.


Women Upper Body Exercise Quality of Life Lymphedema 


  1. 1.
    Breast cancer: statistics on incidence, survival, and screening. Available at: Accessed May 21, 2007Google Scholar
  2. 2.
    Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13(4):589–598PubMedCrossRefGoogle Scholar
  3. 3.
    Palesh O, Collie K, Batiuchok D, et al (2007) A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 75(1):37–44PubMedCrossRefGoogle Scholar
  4. 4.
    Jager G, Doller W, Roth RS (2006) Quality-of-life and body image impairments in patients with lymphedema. Lymphology 39(4):193–200PubMedGoogle Scholar
  5. 5.
    Collado-Hidalgo A, Bower J, Ganz P, Cole S, Irwin M (2006) Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12(9):2759–2766PubMedCrossRefGoogle Scholar
  6. 6.
    Cianfrocca M, Flatters S, Bennett G et al (2006) Peripheral neuropathy in a woman with breast cancer. J Pain 7(1):2–10PubMedCrossRefGoogle Scholar
  7. 7.
    Ott C, Twiss J, Waltman N, Gross G, Lindsey A (2006) Challenges of recruitment of breast cancer survivors to a randomized clinical trial for osteoporosis prevention. Cancer Nurs 29(1):21–31PubMedCrossRefGoogle Scholar
  8. 8.
    Rooney M, Wald A (2007) Interventions for the management of weight and body composition changes in women with breast cancer. Clin J Oncol Nurs 11(1):41–52PubMedCrossRefGoogle Scholar
  9. 9.
    Stubblefield M, Custodio C (2006) Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil 87(3 (suppl 1)):S96–S99PubMedCrossRefGoogle Scholar
  10. 10.
    Collins L, Nash R, Round T, Newman B (2004) Perceptions of upper-body problems during recovery from breast cancer treatment. Support Care Cancer 12(2):106–113PubMedCrossRefGoogle Scholar
  11. 11.
    Satariano W, Ragland DR (1996) Upper-body strength and breast cancer: A comparison of the effects of age and disease. J Gerontol 51A(5):M215–219Google Scholar
  12. 12.
    Hack TF, Cohen L, Katz J, Robson LS, Goss P (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1):143–149PubMedGoogle Scholar
  13. 13.
    McNeely M, Campbell K, Rowe B, Klassen T, Mackey J, Courneya K (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Can Med Assoc J 175(1):34–41CrossRefGoogle Scholar
  14. 14.
    Markes M, Brockow T, Resch K (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database of Syst Rev (online). October 19(4):CD005001Google Scholar
  15. 15.
    Jones L, Demark-Wahnefried W (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7(12):1017–1026PubMedCrossRefGoogle Scholar
  16. 16.
    American College of Sports Medicine (1998) Position stand: The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports and Exerc 30(6):975–991CrossRefGoogle Scholar
  17. 17.
    Cheema B, Abas H, Smith B, et al (in press) Progressive Exercise for Anabolism in Kidney Disease (PEAK): a randomized controlled trial of resistance training during hemodialysis. J Am Soc Nephrol 18(5):1594–1601 Google Scholar
  18. 18.
    Fiatarone Singh MA (2002) Exercise comes of age: Rationale and Recommendations for a geriatric exercise prescription. J Gerontol A Biol Sci Med Sci 57A(5):M262–282Google Scholar
  19. 19.
    Kent H (1996) Breast cancer survivors begin to challenge exercise taboos. Can Med Assoc J 155(7):969–971Google Scholar
  20. 20.
    McKenzie DC (1998) Abreast in a boat: A race against breast cancer. Can Med Assoc J 159(4):376–378Google Scholar
  21. 21.
    Harris SR, Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: A series of case reports. J Surg Oncol 75(2):95–99CrossRefGoogle Scholar
  22. 22.
    Mitchell T, Yakiwchuk C, Griffin K, Gray R, Fitch M (2007) Survivor dragon boating: a vehicle to reclaim and enhance life after treatment for breast cancer. Health Care Women Int 28(2):122–140PubMedCrossRefGoogle Scholar
  23. 23.
    Martyn-St James M, Carroll S (2006) High-intensity resistance training and postmenopausal bone loss: a meta-analysis. Osteoporos Int 17(8):1225–1240PubMedCrossRefGoogle Scholar
  24. 24.
    Verhagen A, de Vet H, de Bie R et al (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51(12):1235–1241PubMedCrossRefGoogle Scholar
  25. 25.
    Herbert R. Confidence Interval Calculator Version 4.1. (Updated 26/01/04). Available at: http://wwwpedrofhsusydeduau/tutorialhtml. Accessed 24 August 2006Google Scholar
  26. 26.
    Becker L. Effect Size Calculators. (Revised 20/03/00). Available at: http://webuccsedu/lbecker/Psy590/escalc3htm. Accessed 25 February 2007Google Scholar
  27. 27.
    Kolden G, Strauman T, Ward A et al (2002) A pilot study of group exercise training (GET) for women with primary breast cancer: Feasibility and health benefits. Psycho-Oncology 11(5):447–456PubMedCrossRefGoogle Scholar
  28. 28.
    Turner J, Hayes S, Reul-Hirche H (2004) Improving the physical status and quality of life of women treated for breast cancer: A pilot study of a structured exercise program. J Surg Oncol 86(3):141–146PubMedCrossRefGoogle Scholar
  29. 29.
    Lane K, Jespersen D, McKenzie D (2005) The effect of a whole body exercise programme and dragon boat training on arm volume and arm circumference in women treated for breast cancer. Eur J Cancer Care 14(4):353–358CrossRefGoogle Scholar
  30. 30.
    Cheema B, Gaul C (2006) Full-body exercise training improves fitness and quality of life in survivors of breast cancer. J Strength Cond Res 20(1):14–21PubMedCrossRefGoogle Scholar
  31. 31.
    Hutnick N, Williams N, Kraemer W et al (2005) Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exerc 37(11):1827–1835PubMedCrossRefGoogle Scholar
  32. 32.
    Nieman D, Cook V, Henson D et al (1995) Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med 16(5):334–337PubMedCrossRefGoogle Scholar
  33. 33.
    McKenzie DC, Kalda AL (2003) Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: A pilot study. J Clin Oncol 21(3):463–466PubMedCrossRefGoogle Scholar
  34. 34.
    Herrero F, San Juan A, Fleck S et al (2006) Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med 27(7):573–580PubMedCrossRefGoogle Scholar
  35. 35.
    Ahmed R, Thomas W, Yee D, Schmitz K (2006) Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 24(18):2765–2772PubMedCrossRefGoogle Scholar
  36. 36.
    Ohira T, Schmitz K, Ahmed R, Yee D (2006) Effects of weight training on quality of life in recent breast cancer survivors. Cancer 106(9):2076–2083PubMedCrossRefGoogle Scholar
  37. 37.
    Schmitz K, Ahmed R, Hannan P, Yee D (2005) Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin and insulin-like growth factor axis proteins. Cancer Epidemiol, Biomarkers Prev 14(7):1588–1595CrossRefGoogle Scholar
  38. 38.
    Courneya K, Segal R, Mackey J et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotheraphy: A multicenter randomized controlled trial. J Clin Oncol (in press) Google Scholar
  39. 39.
    France L, Michie S, Barrett-Lee P, Brain K, Harper P, Gray J (2000) Male cancer: A qualitative study of male breast cancer. Breast 9(6):343–348PubMedCrossRefGoogle Scholar
  40. 40.
    Beck AT, Ward CH, Mendelsen M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  41. 41.
    Hamiton M. (1967) Development of a rating scale for primary depressive illness.Br J Soc Clin Psycho 6:278–296Google Scholar
  42. 42.
    Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales.J Pers Soc Psychol 54(6):1063–1070PubMedCrossRefGoogle Scholar
  43. 43.
    Howard KI, Vessey JT, Leuger R, Schank D (1992) The psychotherapeutic service delivery system. Psychother Res 2(3):164–180Google Scholar
  44. 44.
    Ganz PA, Schag CAC, Lee JJ, et al (1992) The CARES: A generic measure of health-related quality of life for patients with cancer. Qual Life Res 1(1):19–29PubMedCrossRefGoogle Scholar
  45. 45.
    Cella DF, Tulsky DS, Gray G, et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure J Clin Oncol 11(3):570–579PubMedGoogle Scholar
  46. 46.
    Brady MT, Cella DF, Mo F, et al ((1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument J Clin Oncol 15(3):974–986PubMedGoogle Scholar
  47. 47.
    World Health Organization Quality of Life Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551–558Google Scholar
  48. 48.
    Ware JE, Snow KK, Kosinski MK et al (1993) SF–36 Health survey manual and interpretation guide. Nimrod Press, Boston, MAGoogle Scholar
  49. 49.
    Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376Google Scholar
  50. 50.
    Schag CA, Ganz PA, Heinrich RL (1991). Cancer rehabilitation evaluation system—short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68(6):1406–1413PubMedCrossRefGoogle Scholar
  51. 51.
    Rosenberg M (1965) Society and the adolescent self-image. Princeton University, Princeton, NJGoogle Scholar
  52. 52.
    Moher D, Schulz K, Altman D (2001) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomised trials. Lancet 357(9263):1191–1194PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Bobby Cheema
    • 1
  • Catherine A. Gaul
    • 2
  • Kirstin Lane
    • 3
  • Maria A. Fiatarone Singh
    • 4
    • 5
    • 6
  1. 1.Institute of Food, Nutrition and Human Health, Te Kura Hangarua o Kai-oranga-a-tangataMassey UniversityWellingtonNew Zealand
  2. 2.School of Physical EducationUniversity of VictoriaVictoriaCanada
  3. 3.Department of MedicineUniversity of British ColumbiaVancouverCanada
  4. 4.School of Exercise and Sport Science and Faculty of MedicineUniversity of SydneySydneyAustralia
  5. 5.Hebrew SeniorLifeBostonUSA
  6. 6.Jean Mayer USDA Human Nutrition Center on Aging at Tufts UniversityBostonUSA

Personalised recommendations